Search
Get in touch!
Linkedin X-twitter Envelope

Polen Capital: AI is transformative, but..

In this letter to shareholders, the team at Polen Capital shares their thoughts on AI. Despite all the hype, the Polen team has a constructive long-term outlook on AI’s transformative potential but advocates a patient, globally diversified, and active investment approach focused on quality companies, while being mindful of uncertainty and volatility along the way. The firm sees compelling AI opportunities emerging in industries and geographies beyond the current market leaders.

Here are the key points from the letter:

  • The Polen team believes AI will have a transformative impact across nearly every industry in the coming years, but it is still too early to accurately determine the long-term winners and losers.
  • The next phase of AI opportunities will broaden beyond just the tech sector to innovative companies in other industries and regions like Europe and Asia, where valuations appear more attractive.
  • While AI-related stocks have rallied significantly this year, valuations are still much lower than during the dot-com bubble peak in 2000. The largest tech companies currently trade at nearly half the P/E multiples seen in the late 1990s.
  • AI is still in the early stages with much uncertainty around issues like governance, ethics, data security and accuracy. Widespread adoption will take time and market leaders will likely change.
  • AI’s evolution will likely be bumpy as winners and losers emerge. With the heavy concentration in mega-cap tech, investors should be wary that broad index exposure does not provide true diversification currently.

In addition, Polen has also recently published their investor presentation with their outlook for H2 2024 – see the video here.

We think the next leg of AI opportunities will broaden and include innovative companies beyond the tech sector. We also see opportunities outside the U.S.—particularly in Europe and Asia—where valuations appear more attractive.

Click here to go to the external source.

https://www.polencapital.com/perspectives/webinar-replay-global-equity-investing

Share the news

Disclaimer of liability

The above has been prepared by Børsgade ApS for information purposes and cannot be regarded as a solicitation or recommendation to buy or sell any security. Nor can the information etc. be regarded as recommendations or advice of a legal, accounting or tax nature. Børsgade cannot be held liable for losses caused by customers’/users’ actions – or lack thereof – based on the information in the above. We have made every effort to ensure that the information in the above is complete and accurate, but cannot guarantee this and accept no liability for errors or omissions.

Readers are advised that investing may involve a risk of loss that cannot be determined in advance, and that past performance and price development cannot be used as a reliable indicator of future performance and price development. For further information please contact info@borsgade.dk

You might also find this interesting:

Michael Mauboussin: Drawdowns Are The Unavoidable Cost of Long-Term Investing

June 6, 2025

Michael Mauboussin from Morgan Stanley Investment Management have published a comprehensive analysis examining stock market drawdowns and recovery patterns from 1985 to 2024. The research reveals that even the most successful investments experience severe price declines, with the median stock suffering an 85% drawdown that takes 2.5 years from peak to trough.

The study analyzed over 6,500 companies and found that more than half never recover to their previous highs. Michael’s work demonstrates that large drawdowns are an inevitable feature of equity investing, affecting individual stocks, mutual funds, and even portfolios with perfect foresight.

Thomas Gayner: My Current Take on Novo Nordisk

June 6, 2025

In his interview, Tom Gayner, CEO of Markel Group, reflects on investment principles shaped by Warren Buffett and Charlie Munger, and offers a detailed assessment of Novo Nordisk. Gayner praises Novo Nordisk for its business quality, global leadership in diabetes treatment, and strong growth trajectory. He credits the company’s disciplined management and innovation in pharmaceuticals as exemplary, aligning with his own standards of long-term value creation.

Michael Mauboussin: Put Expected Value In Your Valuation Toolkit

May 21, 2025

In this article, Michael Mauboussin explores how investors can generate excess returns by focusing on the gap between price and value, emphasizing the practicalities and psychology of expected value in investment decisions. He explains that while price is observable, value is inherently probabilistic, requiring careful estimation of possible payoffs and their probabilities.

The paper covers the challenges of modeling uncertainty, the importance of considering both probabilities and payoffs, the psychological hurdles investors face (like loss aversion), and best practices for applying these concepts across asset classes.

Bill Ackman: Success is Not A Straight Line Up

May 21, 2025

In the 2025 UBS Berkshire Hathaway Fireside Chat, Bill Ackman and Ryan Israel from Pershing Square Capital discuss investment philosophy, market volatility, the impact of tariffs and geopolitics, and lessons from Warren Buffett.

The conversation covers how to identify durable, high-quality businesses, the importance of long-term thinking, and the evolving landscape for activist investing. Ackman shares personal reflections on resilience, mentorship, and the role of free speech, while both speakers provide practical advice for young investors and fund managers.